“Natural” Hormone Replacement Therapy
... endometrial cancer are equivocal. The limited literature available is based on animal studies and some epidemiological data.2 As a low potency agent, it is somewhat safer than other estrogens; however, continuous use in high doses may have stimulatory effects on breast and endometrial tissue.3 One c ...
... endometrial cancer are equivocal. The limited literature available is based on animal studies and some epidemiological data.2 As a low potency agent, it is somewhat safer than other estrogens; however, continuous use in high doses may have stimulatory effects on breast and endometrial tissue.3 One c ...
Estrogen-Based Hormone Replacement Therapy
... The most common side effects of progestins include breast pain, mood changes, headache, appetite changes and bloating. These side effects seem to be related to the progesterone preparation used, the dosage ratio of progesterone to estrogen, and the use of cyclic vs. continuous progesterone. 6,7 Addi ...
... The most common side effects of progestins include breast pain, mood changes, headache, appetite changes and bloating. These side effects seem to be related to the progesterone preparation used, the dosage ratio of progesterone to estrogen, and the use of cyclic vs. continuous progesterone. 6,7 Addi ...
Advantan - AMPOULE
... (CPB) and BMV, the atrophgenic potential of CBP is highly greater than Advantan and BMV. Though there is no significant difference between Advantan and BMV, the atrophenic potential of Advantan is low. (3) Local symptoms such as atrophy of the skin, telangiectasia, striae, acneform changes of the sk ...
... (CPB) and BMV, the atrophgenic potential of CBP is highly greater than Advantan and BMV. Though there is no significant difference between Advantan and BMV, the atrophenic potential of Advantan is low. (3) Local symptoms such as atrophy of the skin, telangiectasia, striae, acneform changes of the sk ...
Medroxyprogesterone acetate
Medroxyprogesterone acetate (INN, USAN, BAN), also known as 17α-hydroxy-6α-methylprogesterone acetate, and commonly abbreviated as MPA, is a steroidal progestin, a synthetic variant of the steroid hormone progesterone. It is used as a contraceptive, in hormone replacement therapy and for the treatment of endometriosis as well as several other indications.MPA is a more potent derivative of its parent compound medroxyprogesterone (MP). While medroxyprogesterone is sometimes used as a synonym for medroxyprogesterone acetate, what is almost always being referred to is MPA and not MP.It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.